文献速递胃肠外科

经肛与腹腔镜全直肠系膜切除术治疗中低位直肠癌的短期结局单中心比较研究

Single-center comparative study of short-term outcomes of transanal and laparoscopic total mesorectal excisions for low and middle rectal cancers.
PubMed 文献 · Surg Endosc · 2023-03-08

结果显示经肛组手术时间显著更短(p<0.001),环周切缘阳性率显著更低(p=0.04),Clavien-Dindo III级(p=0.02)和IV级(p=0.03)并发症发生率显著更低,两组远端切缘阳性率均为0%。

要点

  • 经肛组手术时间显著短于腹腔镜组(p<0.001)。
  • 经肛组环周切缘阳性率显著低于腹腔镜组(p=0.04)。
  • 经肛组Clavien-Dindo III级和IV级并发症发生率显著更低。

核心结论

  • 与腹腔镜相比,经肛全直肠系膜切除术治疗中低位直肠癌的术后并发症发生率和环周切缘阳性率更低,显示其安全性和局部根治性。

主要发现

  • 经肛组手术时间显著短于腹腔镜组(p<0.001)。
  • 两组病理T分期和N状态无显著差异。
  • 经肛组环周切缘阳性率显著低于腹腔镜组(p=0.04)。
  • 经肛组Clavien-Dindo III级(p=0.02)和IV级(p=0.03)并发症发生率显著低于腹腔镜组。
  • 两组远端切缘阳性率均为0%。

关键数值与推荐

  • 环周切缘≤1 mm定义为阳性。
  • 中位直肠癌定义为5-10 cm,低位直肠癌定义为<5 cm。

临床怎么用

  • 对于中低位直肠癌,经肛全直肠系膜切除术可作为安全且局部根治性良好的术式选择。

局限性

  • 本研究为单中心回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transanal total mesorectal excision is a promising surgical treatment for rectal cancer. However, evidence regarding the differences in outcomes between the transanal and laparoscopic total mesorectal excisions is scarce. We compared the short-term outcomes of transanal and laparoscopic total mesorectal excisions for low and middle rectal cancers. METHODS: This retrospective study included patients who underwent low anterior or intersphincteric resection for middle (5-10 cm) or low (< 5 cm) rectal cancer at the National Cancer Center Hospital East, Japan, from May 2013 to March 2020. Primary rectal adenocarcinoma was confirmed histologically. Circumferential resection margins (CRMs) of resected specimens were measured; margins ≤ 1 mm were considered positive. The operative time, blood loss, hospitalization length, postoperative readmission rate, and short-term treatment results were compared. RESULTS: Four hundred twenty-nine patients were divided into two mesorectal excision groups: transanal (n = 295) and laparoscopic (n = 134). Operative times were significantly shorter in the transanal group than in the laparoscopic group (p < 0.001). The pathological T stage and N status were not significantly different. The transanal group had significantly lower positive CRM rates (p = 0.04), and significantly lower incidence of the Clavien-Dindo grade III (p = 0.02) and IV (p = 0.03) complications. Both groups had distal margin positivity rates of 0%. CONCLUSIONS: Compared to laparoscopic, transanal total mesorectal excision for low and middle rectal cancers has lower incident postoperative complication and CRM-positivity rates, demonstrating the safety and usefulness of local curability for middle and low rectal cancers.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Adachi T, Kitaguchi D, Teramura K, et al. Single-center comparative study of short-term outcomes of transanal and laparoscopic total mesorectal excisions for low and middle rectal cancers. Surg Endosc. 2023. PMID: 36890411. doi:10.1007/s00464-023-09948-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。